Aortic Disease Program
The MaineHealth Aortic Disease Program provides comprehensive care and state-of-the-art surgical procedures for patients with a wide range of aortic diseases and conditions.
Our team of multidisciplinary experts—including vascular and cardiac surgeons, geneticists and cardiologists—work together to centralize care of aortic pathologies. Patients who are appropriate candidates for care with the Aortic Disease Program benefit from our specialists’ shared decision-making and streamlined approach to care.
We diagnose and treat a wide range of aortic conditions and diseases such as:
- Bicuspid aortic valve and associated aortopathy
- Loeys-Dietz syndrome
- Marfan syndrome
- Vascular Ehlers-Danlos
Aortic Aneurysms
- Abdominal aortic aneurysm
- Thoracic aortic aneurysm
- Ascending aortic aneurysm
- Aortic arch aneurysm
- Descending aneurysm
- Thoraco-abdominal aortic aneurysm
- Aneurysm of branch vessels
- Saccular aneurysms
Other Aortic Pathologies
- Thoracic dissections, including
- Ascending
- Arch
- Descending
- Occlusive pathology
- Intralumenal thrombosis
- Atheroma
- Arteritis
- Inflammatory pathologies
- Giant cell aortitis
- Infective aortitis
- Intramural hematoma
- Penetrating aortic ulcer
Services include:
Abdominal aortic aneurysm repair & replacement
- Open aortic repair and replacement
- Endovascular aneurysm repair (EVAR)
- Fenestrated endovascular aortic repair (FEVAR)
- Chimney endovascular aortic repair (ChEVAR)
- Branched endovascular Iliac repair (IBE)
Thoracic aortic aneurysm repair
- Open aortic repair and replacement
- Thoracic endovascular aortic repair (TEVAR)
- Elephant trunk repair
- Thoraco-abdominal repair
- Aortic root repair and replacement
- Debranching procedure
- Medtronic Endurant EVO Clinical Trial (concluded 2021) which demonstrated the safe and effective use of the Endurant Evo AAA stent graft system for endovascular treatment of abdominal aortic aneurysms (AAA)
- MaineHealth participates in the VQI-VISION (Vascular Quality Initiative – Vascular Implant Surveillance & Interventional Outcomes Network) Steering Committee, which is a partnership among institutions VQI, CMS, FDA, and industry, to investigate device-specific outcomes.